Pharmacotherapy of epilepsy: new solutions to old problems

Cover Page

Cite item

Full Text

Abstract

The literature review provides an update on recent advances in antiepileptic pharmacotherapy. The article considers the mechanisms of action of the drugs, the range of efficacy, side effects and enzyme-inducing properties, potential teratogenicity.

A review of the literature revealed some of the problems of patients with epilepsy remaining unresolved to this day. Despite an increase in the number of anticonvulsants in recent years, one-third of patients are pharmacoresistant to antiepileptic therapy and continue to suffer from seizures. The hope for reducing the proportion of patients with uncontrolled seizures rests on future therapeutic developments, including targeted therapies aimed at the molecular mechanisms underlying the epilepsy pathogenesis. Clinical outcomes in patients with epilepsy could also significantly improve with advances in the development of new highly accurate diagnostic and treatment methods, the identification of biomarkers for drug development, as well as routine clinical follow-up and the introduction of truly innovative disease-modifying therapies.

About the authors

Anton S. Romanov

Altai State Medical University

Author for correspondence.
Email: anton.joerom@gmail.com
ORCID iD: 0000-0001-6641-8803
SPIN-code: 9779-6202

a postgraduate student of the Department of pharmacy

Russian Federation, Barnaul

Elena F. Sharahova

Altai State Medical University

Email: shef3100@yandex.ru
ORCID iD: 0000-0002-3143-8748
SPIN-code: 8648-7863

PhD, Professor, Head of the Department of pharmacy

Russian Federation, Barnaul

References

  1. Perucca P, Scheffer IE, Kiley M. The management of epilepsy in children and adults. Medical Journal of Australia. 2018;208(5):226-233. doi: 10.5694/mja17.00951
  2. Thijs RD, Surges R, O’Brien TJ. Epilepsy in adults. Lancet. 2019;393(10172):689-701. doi: 10.1016/s0140-6736(18)32596-0
  3. Löscher W, Klein P. The feast and famine: epilepsy treatment and treatment gaps in early 21st century. Neuropharmacology. 2020;170(108055). doi: 10.1016/j.neuropharm.2020.108055
  4. Sankaraneni R, Lachhwani D. Antiepileptic Drugs - A Review. Pediatric Annals. 2015;44(2):36-42. doi: 10.3928/00904481-20150203-10
  5. Perucca E. The pharmacological treatment of epilepsy: recent advances and future perspectives. Acta Epileptologica. 2021;3(22). doi: 10.1186/s42494-021-00055-z
  6. Perucca E. Antiepileptic drugs: evolution of our knowledge and changes in drug trials. Epileptic Disord. 2019;21(4):319-329. doi: 10.1684/epd.2019.1083
  7. Drug Approvals and Databases. Avialable at: https://www.fda.gov/drugs/development-approval-process-drugs/drug-approvals-and-databases (08 September 2022)
  8. Mula M. Pharmacological treatment of focal epilepsy in adults: an evidence based approaches. Expert Opinion on Pharmacotherapy. 2020. doi: 10.1080/14656566.2020.1829594
  9. Dhir A. Cenobamate for the treatment of focal epilepsy. Drugs of Today. 2020;56(4):233-240. doi: 10.1358/dot.2020.56.4.3127030
  10. Lattanzi S, Brigo F, Trinka E, et al. Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety. CNS Drugs. 2020;34(3):229-241. doi: 10.1007/s40263-020- 00708-6
  11. Gogou M, Cross JH. Fenfluramine as antiseizure medication for epilepsy. Developmental Medicine & Child Neurology. 2021;63(8):899-907. doi: 10.1111/dmcn.14822
  12. Fedak Romanowski EM, McNamara NA, Neil EE, Gottlieb-Smith R, Dang LT. Seizure rescue medications for out-of-hospital use in children. J Pediatr. 2021;229:19-25. doi: 10.1016/j.jpeds.2020.10.041
  13. Bouw MR, Chung SS, Gidal B et al. Clinical pharmacokinetic and pharmacodynamic profile of midazolam nasal spray. Epilepsy Res. 2021;171. doi: 10.1016/j.eplepsyres.2021.106567
  14. Boddu SHS, Kumari S. A short review on the intranasal delivery of diazepam for treating acute repetitive seizures. Pharmaceutics. 2020;12(12):1167. doi: pharmaceutics12121167
  15. Perucca E, Brodie MJ, Kwan P, Tomson T. 30 years of second-generation antiseizure medications: impact and future perspectives. Lancet Neurol. 2020;19:544-556. doi: 10.1016/S1474-4422(20)30035-1
  16. Perucca E, French J, Bialer M. Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet Neurol. 2007;6(9):793-804. doi: 10.1016/s1474-4422(07)70215-6
  17. Schindler W, Häfliger F. Uber Derivate des Iminodibenzyls. Helvetica Chimica Acta. 1954;37(2):472-483. doi: 10.1002/hlca.19540370211
  18. Kwan P, Sills GJ, Brodie MJ. The mechanisms of action of commonly used antiepileptic drugs. Pharmacology & Therapeutics. 2001;90(1):21-34. doi: 10.1016/s0163-7258(01)00122-x-
  19. Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nature Reviews Neuroscience. 2004;5(7):553-564. doi: 10.1038/nrn1430
  20. Genton P. When antiepileptic drugs aggravate epilepsy. Brain and Development. 2000; 22(2):75-80. doi: 10.1016/s0387-7604(99)00113-8
  21. Perucca P, Mula M. Antiepileptic drug effects on mood and behavior: Molecular targets. Epilepsy & Behavior. 2013;26(3):440-449. doi: 10.1016/j.yebeh.2012.09.018
  22. Witt JA, Helmstaedter C. How can we overcome neuropsychological adverse effects of antiepileptic drugs? Expert opinion on pharmacotherapy. 2017;18(6):551-554. doi: 10.1080/14656566.2017.1309025
  23. Mula M. Investigating psychotropic properties of antiepileptic drugs. Expert Rev Neurother. 2013;13(6)639-646. doi: 10.1586/ern.13.57
  24. Brodie MJ, Besag FMC, Ettinger AB, Mula M, et. al. Epilepsy, antiepileptic drugs, and aggression: an evidence-based review. Pharmacol Rev. 2016;68(3):563-602. doi: 10.1124/pr.115.012021
  25. Park SP, Kwon SH. Cognitive Effects of Antiepileptic Drugs. J Clin Neurol. 2008;4(3):99-106. doi: 10.3988/jcn.2008.4.3.99
  26. Abou-Khalil BW. Update on Antiepileptic Drugs 2019. CONTINUUM: Lifelong Learning in Neurology. 2019;25(2):508-536. doi: 10.1212/con.0000000000000715
  27. Kovaleva IYu. Adverse effects of antiepileptic drugs. Epilepsy and paroxysmal conditions. 2017;9(1):51-61. (In Russ.). [Ковалева И.Ю. Побочные эффекты антиэпилептической терапии. Эпилепсия и пароксизмальные состояния. 2017;9(1):51-61]. doi: 10.17749/2077-8333.2017.9.1.051-061
  28. Vidaurre J, Herbst J. New antiepileptic drugs. Medicina (B Aires). 2019;79(3):48-53. URL http://www.medicinabuenosaires.com/PMID/31603844.pdf
  29. Patsalos PN. Properties of Antiepileptic Drugs in the Treatment of Idiopathic Generalized Epilepsies. Epilepsia. 2005;46(9):140-148. doi: 10.1111/j.1528-1167.2005.00326.x
  30. Brodie MJ. Sodium Channel Blockers in the Treatment of Epilepsy. CNS Drugs. 2017;31(7):527-534. doi: 10.1007/s40263-017-0441-0

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Figure 1. Examples of chemical structure progress in the development of antiepileptic drugs [16, 17].

Download (354KB)
Indexing metadata

Copyright (c) 2023 Romanov A.S., Sharahova E.F.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).